Package 50458-290-01

{"route": ["ORAL"], "spl_id": "b5d1c275-8665-4f63-8232-e34a02c998c7", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000185503", "N0000190113"], "upc": ["0350458290042"], "unii": ["304NUG5GF4"], "rxcui": ["311204", "833164"], "spl_set_id": ["a4d555fa-787c-40fb-bb7d-b0d4f7318fd0"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]"], "manufacturer_name": ["Janssen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 BLISTER PACK in 1 CARTON (50458-290-01)  / 10 CAPSULE in 1 BLISTER PACK", "package_ndc": "50458-290-01", "marketing_end_date": "20261130", "marketing_start_date": "19920911"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (50458-290-04)", "package_ndc": "50458-290-04", "marketing_end_date": "20261130", "marketing_start_date": "19920911"}], "brand_name": "SPORANOX", "product_id": "50458-290_b5d1c275-8665-4f63-8232-e34a02c998c7", "dosage_form": "CAPSULE", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "50458-290", "generic_name": "ITRACONAZOLE", "labeler_name": "Janssen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SPORANOX", "active_ingredients": [{"name": "ITRACONAZOLE", "strength": "100 mg/1"}], "application_number": "NDA020083", "marketing_category": "NDA", "marketing_end_date": "20261130", "marketing_start_date": "19920911"}